- Home
- ILPT vs SLP Comparison
ILPT vs SLP Comparison
Compare ILPT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- SLP
- Stock Information
- Founded
- ILPT 2017
- SLP 1996
- Country
- ILPT United States
- SLP United States
- Employees
- ILPT N/A
- SLP N/A
- Industry
- ILPT Real Estate Investment Trusts
- SLP EDP Services
- Sector
- ILPT Real Estate
- SLP Technology
- Exchange
- ILPT Nasdaq
- SLP Nasdaq
- Market Cap
- ILPT 400.0M
- SLP 322.4M
- IPO Year
- ILPT 2018
- SLP 1997
- Fundamental
- Price
- ILPT $5.48
- SLP $16.47
- Analyst Decision
- ILPT
- SLP Buy
- Analyst Count
- ILPT 0
- SLP 8
- Target Price
- ILPT N/A
- SLP $26.80
- AVG Volume (30 Days)
- ILPT 359.6K
- SLP 675.6K
- Earning Date
- ILPT 10-28-2025
- SLP 10-23-2025
- Dividend Yield
- ILPT 3.65%
- SLP N/A
- EPS Growth
- ILPT N/A
- SLP N/A
- EPS
- ILPT N/A
- SLP N/A
- Revenue
- ILPT $443,468,000.00
- SLP $80,383,000.00
- Revenue This Year
- ILPT $3.44
- SLP $12.76
- Revenue Next Year
- ILPT $1.78
- SLP $2.82
- P/E Ratio
- ILPT N/A
- SLP N/A
- Revenue Growth
- ILPT 0.36
- SLP 20.01
- 52 Week Low
- ILPT $2.45
- SLP $12.39
- 52 Week High
- ILPT $6.57
- SLP $37.67
- Technical
- Relative Strength Index (RSI)
- ILPT 40.20
- SLP 68.42
- Support Level
- ILPT $5.53
- SLP $14.46
- Resistance Level
- ILPT $5.75
- SLP $16.80
- Average True Range (ATR)
- ILPT 0.20
- SLP 0.59
- MACD
- ILPT -0.08
- SLP 0.16
- Stochastic Oscillator
- ILPT 11.82
- SLP 88.68
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.